Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-13-001755
Filing Date
2013-08-27
Accepted
2013-08-27 18:45:04
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 13285
  Complete submission text file 0001078782-13-001755.txt   14734
Mailing Address 150 ORCHARD ROAD ORCHARD PLAZA 08-02 U0 238841
Business Address 150 ORCHARD ROAD ORCHARD PLAZA 08-02 U0 238841 000-000-0000
VOLITIONRX LTD (Issuer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 49 A/B HANOVERGATE MANSIONS PARK RD LONDON X0 NW1 4SN
Business Address
Reynolds Cameron John (Reporting) CIK: 0001340610 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-30402 | Film No.: 131063889